Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma
Authors
Keywords
-
Journal
PLoS Genetics
Volume 10, Issue 1, Pages e1004107
Publisher
Public Library of Science (PLoS)
Online
2014-01-17
DOI
10.1371/journal.pgen.1004107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- IL-4 receptor blockade abrogates satellite cell: Rhabdomyosarcoma fusion and prevents tumor establishment
- (2013) Guangheng Li et al. STEM CELLS
- IGF1 Receptor Signaling Regulates Adaptive Radioprotection in Glioma Stem Cells
- (2013) Satoru Osuka et al. STEM CELLS
- An adaptive Src–PDGFRA–Raf axis in rhabdomyosarcoma
- (2012) Jinu Abraham et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
- (2012) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma
- (2012) K Kikuchi et al. ONCOGENE
- Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma
- (2011) Abha A. Gupta et al. CANCER
- Formation of solid tumors by a single multinucleated cancer cell
- (2011) Zhang Weihua et al. CANCER
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
- (2010) L. Cao et al. CANCER RESEARCH
- Genes that Modulate the Sensitivity for Anti-Microtubule Drug-Mediated Chemotherapy
- (2010) H.Y. Yamada et al. CURRENT CANCER DRUG TARGETS
- Fusion-Negative Alveolar Rhabdomyosarcoma: Modification of Risk Stratification Is Premature
- (2010) James R. Anderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosing Alveolar Rhabdomyosarcoma: Morphology Must Be Coupled With Fusion Confirmation
- (2010) Leonard H. Wexler et al. JOURNAL OF CLINICAL ONCOLOGY
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
- (2009) K. Nishijo et al. CANCER RESEARCH
- DNA damage checkpoint inactivation: Adaptation and recovery
- (2009) Céline Clémenson et al. DNA REPAIR
- Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
- (2009) K. Hu et al. MOLECULAR CANCER THERAPEUTICS
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
- (2009) Haihao Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma
- (2008) E Taniguchi et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now